Ese-3 contributes to colon cancer progression by downregulating EHD2 and transactivating INPP4B

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• Epithelium-specific Ets protein 3 (Ese-3) is an Ets family transcription factor implicated in various cancers.
• The specific role of Ese-3 in colon cancer (CC) pathogenesis remains largely unexplored.

Purpose of the Study:

• To investigate the role and mechanism of Ese-3 in colon cancer development.
• To identify downstream targets of Ese-3 in CC.

Main Methods:

• Analysis of Ese-3 expression in CC tissues.
• In vitro and in vivo experiments involving Ese-3 knockdown and overexpression in CC cells.
• Investigation of downstream genes EHD2 and INPP4B.

Main Results:

• Ese-3 expression is upregulated in CC tissues and correlates with advanced T stage and poorer disease-free survival.
• Ese-3 knockdown inhibits CC cell proliferation, while overexpression enhances it.
• Ese-3 downregulates EHD2 and transactivates INPP4B, with EHD2 downregulation promoting CC cell proliferation.

Conclusions:

• Ese-3 promotes colon cancer cell proliferation by downregulating EHD2 and transactivating INPP4B.
• Ese-3 serves as an independent prognostic marker for CC patients.
• Targeting the Ese-3/EHD2/INPP4B pathway presents a potential therapeutic avenue for colon cancer.